1. Zhang, J, Sun, L, Withanage, M H H, Lei, Y L, Zhang, S. 2022. TRAF3IP2-IL-17 Axis Strengthens the Gingival Defense against Pathogens. In Journal of dental research, 102, 103-115. doi:10.1177/00220345221123256. https://pubmed.ncbi.nlm.nih.gov/36281065/
2. Ciccacci, Cinzia, Biancone, Livia, Di Fusco, Davide, Novelli, Giuseppe, Borgiani, Paola. 2012. TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in inflammatory bowel disease. In Journal of Crohn's & colitis, 7, 44-52. doi:10.1016/j.crohns.2012.02.020. https://pubmed.ncbi.nlm.nih.gov/22445837/
3. Perricone, Carlo, Ciccacci, Cinzia, Ceccarelli, Fulvia, Conti, Fabrizio, Borgiani, Paola. 2013. TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development. In Immunogenetics, 65, 703-9. doi:10.1007/s00251-013-0717-6. https://pubmed.ncbi.nlm.nih.gov/23836313/
4. Izadpanah, Amin, Daneshimehr, Fatemeh, Willingham, Kurtis, Alt, Eckhard U, Izadpanah, Reza. 2022. Targeting TRAF3IP2 inhibits angiogenesis in glioblastoma. In Frontiers in oncology, 12, 893820. doi:10.3389/fonc.2022.893820. https://pubmed.ncbi.nlm.nih.gov/36046049/
5. Moon, Christine S, Reglero, Clara, Cortes, Jose R, Palomero, Teresa, Ferrando, Adolfo A. 2021. FYN-TRAF3IP2 induces NF-κB signaling-driven peripheral T cell lymphoma. In Nature cancer, 2, 98-113. doi:10.1038/s43018-020-00161-w. https://pubmed.ncbi.nlm.nih.gov/33928261/
6. Xiang, Qin, Chen, Lu, Hou, Shengping, Kijlstra, Aize, Yang, Peizeng. 2014. TRAF5 and TRAF3IP2 gene polymorphisms are associated with Behçet's disease and Vogt-Koyanagi-Harada syndrome: a case-control study. In PloS one, 9, e84214. doi:10.1371/journal.pone.0084214. https://pubmed.ncbi.nlm.nih.gov/24416204/
7. Sakamuri, Siva S V P, Valente, Anthony J, Siddesha, Jalahalli M, Gardner, Jason D, Bysani, Chandrasekar. 2016. TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosis. In Molecular and cellular endocrinology, 429, 84-92. doi:10.1016/j.mce.2016.03.038. https://pubmed.ncbi.nlm.nih.gov/27040306/
8. Sakamuri, Siva Sankara Vara Prasad, Higashi, Yusuke, Sukhanov, Sergiy, Siebenlist, Ulrich, Chandrasekar, Bysani. 2016. TRAF3IP2 mediates atherosclerotic plaque development and vulnerability in ApoE(-/-) mice. In Atherosclerosis, 252, 153-160. doi:10.1016/j.atherosclerosis.2016.05.029. https://pubmed.ncbi.nlm.nih.gov/27237075/
9. Erikson, John M, Valente, Anthony J, Mummidi, Srinivas, Siebenlist, Ulrich, Chandrasekar, Bysani. 2017. Targeting TRAF3IP2 by Genetic and Interventional Approaches Inhibits Ischemia/Reperfusion-induced Myocardial Injury and Adverse Remodeling. In The Journal of biological chemistry, 292, 2345-2358. doi:10.1074/jbc.M116.764522. https://pubmed.ncbi.nlm.nih.gov/28053087/